Next Milestone Ventures
Colonai
Technologies
Medical Device
Indication
Autoimmune & Inflammation
Central Nervous System Disorders
Disease Surveillance
Metabolic Disease
Obesity
Oncology
Website
colonai.comAdditional Information
Women Owned
Drew Afromsky
Colonai develops artificial intelligence-enabled software guidance systems to improve colorectal cancer screening by preventing two key problems during colonoscopy: missed tumors and incompletely removed tumors.
Corporate Supporter
Westchester County Biosciences Accelerator is a Program of
Initiated by
